1. Home
  2. TOVX vs VERB Comparison

TOVX vs VERB Comparison

Compare TOVX & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • VERB
  • Stock Information
  • Founded
  • TOVX 2001
  • VERB 2014
  • Country
  • TOVX United States
  • VERB United States
  • Employees
  • TOVX N/A
  • VERB N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • VERB Other Consumer Services
  • Sector
  • TOVX Health Care
  • VERB Consumer Discretionary
  • Exchange
  • TOVX Nasdaq
  • VERB Nasdaq
  • Market Cap
  • TOVX 4.7M
  • VERB 4.7M
  • IPO Year
  • TOVX 2006
  • VERB N/A
  • Fundamental
  • Price
  • TOVX $1.18
  • VERB $4.31
  • Analyst Decision
  • TOVX Strong Buy
  • VERB Strong Buy
  • Analyst Count
  • TOVX 1
  • VERB 1
  • Target Price
  • TOVX $6.00
  • VERB $100.00
  • AVG Volume (30 Days)
  • TOVX 23.5K
  • VERB 33.5K
  • Earning Date
  • TOVX 05-06-2025
  • VERB 05-09-2025
  • Dividend Yield
  • TOVX N/A
  • VERB N/A
  • EPS Growth
  • TOVX N/A
  • VERB N/A
  • EPS
  • TOVX N/A
  • VERB N/A
  • Revenue
  • TOVX N/A
  • VERB $895,000.00
  • Revenue This Year
  • TOVX N/A
  • VERB $36.76
  • Revenue Next Year
  • TOVX N/A
  • VERB N/A
  • P/E Ratio
  • TOVX N/A
  • VERB N/A
  • Revenue Growth
  • TOVX N/A
  • VERB 1320.63
  • 52 Week Low
  • TOVX $1.03
  • VERB $4.29
  • 52 Week High
  • TOVX $12.25
  • VERB $53.60
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 44.04
  • VERB 36.22
  • Support Level
  • TOVX $1.08
  • VERB $4.51
  • Resistance Level
  • TOVX $1.21
  • VERB $4.99
  • Average True Range (ATR)
  • TOVX 0.07
  • VERB 0.54
  • MACD
  • TOVX 0.00
  • VERB -0.07
  • Stochastic Oscillator
  • TOVX 57.89
  • VERB 0.95

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

Share on Social Networks: